Roswell Park Comprehensive Cancer Center is intensifying its efforts to increase lung cancer early detection in the greater Buffalo, New York, area by partnering with Denver-based Eon to leverage the health-tech company’s proprietary artificial intelligence patient management software.

Roswell Park Comprehensive Cancer Center is announcing its latest slate of physician promotions, including naming Julia Faller, DO, as Chief Medical Officer.

Expanding access to a breakthrough treatment option for patients with metastatic melanoma, Roswell Park Comprehensive Cancer Center has been approved to administer the newly FDA-approved tumor-infiltrating lymphocyte (TIL) therapy Amtagvi. This “living drug” cell therapy is manufactured by Iovance Biotherapeutics.